This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Other. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Marco Consumi: Innovator in Biocompatible Polymers
Introduction
Marco Consumi is a notable inventor based in Siena, Italy. He has made significant contributions to the field of biocompatible polymers, particularly through his innovative patent related to sulphated hyaluronic acid.
Latest Patents
Marco Consumi holds a patent for "Sulphated hyaluronic acid and sulphated derivatives thereof covalently bound to polyurethanes, and the process for their preparation." This invention focuses on the synthesis of a haemocompatible polymer, which consists of a polyurethane covalently bound to sulphated hyaluronic acid. The sulfated derivatives exhibit anticoagulative, non-thrombogenic, antiviral, and anti-inflammatory properties. They also inhibit platelet adhesion, aggregation, and activation. This invention is particularly advantageous as it resists the enzyme hyaluronidase, ensuring anti-coagulant activities for extended periods compared to similar compounds. The biocompatible polymer material is well-suited for surgical and medicinal applications.
Career Highlights
Throughout his career, Marco Consumi has worked with various organizations, including the Consorzio Interuniversitario Nazionale Per La Scienza E Tecnologia Dei Materiali. His work has been instrumental in advancing the understanding and application of biocompatible materials in medical settings.
Collaborations
Marco has collaborated with notable individuals in his field, including Rolando Barbucci and Agnese Magnani. Their joint efforts have contributed to the development of innovative solutions in polymer science.
Conclusion
Marco Consumi's contributions to the field of biocompatible polymers highlight his innovative spirit and dedication to advancing medical technology. His patent demonstrates the potential for improved surgical materials that can enhance patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile